Header Logo

Connection

Igor Koralnik to Humans

Back to Details
This is a "connection" page, showing publications Igor Koralnik has written about Humans.
Igor Koralnik
Connection Strength
2.111
Humans
  1. Postacute Sequelae of SARS-CoV-2 Infection. JAMA. 2023 10 17; 330(15):1491-1492.
    View in: PubMed
    Score: 0.067
  2. SARS-CoV-2-Specific Immune Responses in Patients With Postviral Syndrome After Suspected COVID-19. Neurol Neuroimmunol Neuroinflamm. 2023 11; 10(6).
    View in: PubMed
    Score: 0.066
  3. Neuro-PASC is characterized by enhanced CD4+ and diminished CD8+ T cell responses to SARS-CoV-2 Nucleocapsid protein. Front Immunol. 2023; 14:1155770.
    View in: PubMed
    Score: 0.065
  4. Neurologic Manifestations of Long COVID Differ Based on Acute COVID-19 Severity. Ann Neurol. 2023 07; 94(1):146-159.
    View in: PubMed
    Score: 0.065
  5. Global Teleneurology. Ann Neurol. 2022 04; 91(4):443-444.
    View in: PubMed
    Score: 0.060
  6. LTA4H Prevalence and Mortality in Adult Zambians with Tuberculous Meningitis. Ann Neurol. 2021 12; 90(6):994-998.
    View in: PubMed
    Score: 0.058
  7. Reader Response: A Prospective Study of Neurologic Disorders in Hospitalized Patients With COVID-19 in New York City. Neurology. 2021 03 16; 96(11):550.
    View in: PubMed
    Score: 0.056
  8. Reply to COVID-19 encephalopathy, Bayes rule, and a plea for case-control studies. Ann Clin Transl Neurol. 2021 03; 8(3):726.
    View in: PubMed
    Score: 0.056
  9. Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients. Ann Clin Transl Neurol. 2020 11; 7(11):2221-2230.
    View in: PubMed
    Score: 0.054
  10. Children with Narcolepsy type 1 have increased T-cell responses to orexins. Ann Clin Transl Neurol. 2019 12; 6(12):2566-2572.
    View in: PubMed
    Score: 0.051
  11. Prospective Cohort Study on Performance of Cerebrospinal Fluid (CSF) Xpert MTB/RIF, CSF Lipoarabinomannan (LAM) Lateral Flow Assay (LFA), and Urine LAM LFA for Diagnosis of Tuberculous Meningitis in Zambia. J Clin Microbiol. 2019 08; 57(8).
    View in: PubMed
    Score: 0.050
  12. Can Immune Checkpoint Inhibitors Keep JC Virus in Check? N Engl J Med. 2019 04 25; 380(17):1667-1668.
    View in: PubMed
    Score: 0.049
  13. Developing a successful global neurology program. Ann Neurol. 2017 02; 81(2):167-170.
    View in: PubMed
    Score: 0.042
  14. Brief Report: Role of Thymic Reconstitution in the Outcome of AIDS-Related PML. J Acquir Immune Defic Syndr. 2015 Dec 01; 70(4):357-61.
    View in: PubMed
    Score: 0.039
  15. Lack of Major Histocompatibility Complex Class I Upregulation and Restrictive Infection by JC Virus Hamper Detection of Neurons by T Lymphocytes in the Central Nervous System. J Neuropathol Exp Neurol. 2015 Aug; 74(8):791-803.
    View in: PubMed
    Score: 0.038
  16. JC virus-iLOV fluorescent strains enable the detection of early and late viral protein expression. J Virol Methods. 2015 Oct; 223:25-9.
    View in: PubMed
    Score: 0.038
  17. Novel syndromes associated with JC virus infection of neurons and meningeal cells: no longer a gray area. Curr Opin Neurol. 2015 Jun; 28(3):288-94.
    View in: PubMed
    Score: 0.038
  18. Training for a neurology career in a rare disease: The role of cyberconsults. Ann Neurol. 2015 May; 77(5):738-40.
    View in: PubMed
    Score: 0.037
  19. Finger pointing to JC virus: a tale of two indexes. Ann Neurol. 2014 Dec; 76(6):789-91.
    View in: PubMed
    Score: 0.036
  20. JCV GCN in a natalizumab-treated MS patient is associated with mutations of the VP1 capsid gene. Neurology. 2014 Aug 19; 83(8):727-32.
    View in: PubMed
    Score: 0.035
  21. JC virus reactivation during prolonged natalizumab monotherapy for multiple sclerosis. Ann Neurol. 2014 Jun; 75(6):925-34.
    View in: PubMed
    Score: 0.035
  22. Hyperintense cortical signal on magnetic resonance imaging reflects focal leukocortical encephalitis and seizure risk in progressive multifocal leukoencephalopathy. Ann Neurol. 2014 May; 75(5):659-69.
    View in: PubMed
    Score: 0.035
  23. Molecular diagnosis of central nervous system opportunistic infections in HIV-infected Zambian adults. Clin Infect Dis. 2014 Jun; 58(12):1771-7.
    View in: PubMed
    Score: 0.035
  24. Agnogene deletion in a novel pathogenic JC virus isolate impairs VP1 expression and virion production. PLoS One. 2013; 8(11):e80840.
    View in: PubMed
    Score: 0.034
  25. Hyperperfusion in progressive multifocal leukoencephalopathy is associated with disease progression and absence of immune reconstitution inflammatory syndrome. Brain. 2013 Nov; 136(Pt 11):3441-50.
    View in: PubMed
    Score: 0.033
  26. Inflammatory infratentorial progressive multifocal leukoencephalopathy in a patient with rheumatoid arthritis. Neuropathology. 2014 Feb; 34(1):39-44.
    View in: PubMed
    Score: 0.033
  27. Detection of JC virus-specific immune responses in a novel humanized mouse model. PLoS One. 2013; 8(5):e64313.
    View in: PubMed
    Score: 0.033
  28. Comment: avoiding detrimental effects of corticosteroids on JC virus T-cell responses--primum non nocere. Neurology. 2012 Dec 04; 79(23):2263.
    View in: PubMed
    Score: 0.032
  29. JC virus encephalopathy is associated with a novel agnoprotein-deletion JCV variant. PLoS One. 2012; 7(4):e35793.
    View in: PubMed
    Score: 0.030
  30. Simultaneous PML-IRIS after discontinuation of natalizumab in a patient with MS. Neurology. 2012 May 01; 78(18):1390-3.
    View in: PubMed
    Score: 0.030
  31. Progressive multifocal leukoencephalopathy in a patient without immunodeficiency. Neurology. 2012 Jan 03; 78(1):73; author response 73-4.
    View in: PubMed
    Score: 0.030
  32. Hidden in plain view: emergence of progressive multifocal leukoencephalopathy after treatment of CNS toxoplasmosis. Acta Neurol Belg. 2011 Sep; 111(3):217-9.
    View in: PubMed
    Score: 0.029
  33. Role of CD4+ and CD8+ T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome. J Virol. 2011 Jul; 85(14):7256-63.
    View in: PubMed
    Score: 0.028
  34. Discrepant findings in immune responses to JC virus in patients receiving natalizumab. Lancet Neurol. 2010 Jun; 9(6):565-6; author reply 566-7.
    View in: PubMed
    Score: 0.027
  35. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol. 2010 Apr; 9(4):425-37.
    View in: PubMed
    Score: 0.026
  36. Role of human leukocyte antigen class I alleles in progressive multifocal leukoencephalopathy. J Neurovirol. 2010 Feb; 16(1):41-7.
    View in: PubMed
    Score: 0.026
  37. The spectrum of neurological disorders in a Zambian tertiary care hospital. J Neurol Sci. 2010 Mar 15; 290(1-2):1-5.
    View in: PubMed
    Score: 0.026
  38. Determinants of survival in progressive multifocal leukoencephalopathy. Neurology. 2009 Nov 10; 73(19):1551-8.
    View in: PubMed
    Score: 0.026
  39. Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression. J Neurol Neurosurg Psychiatry. 2010 Mar; 81(3):247-54.
    View in: PubMed
    Score: 0.025
  40. Asymptomatic reactivation of JC virus in patients treated with natalizumab. N Engl J Med. 2009 Sep 10; 361(11):1067-74.
    View in: PubMed
    Score: 0.025
  41. Rearrangement of the JC virus regulatory region sequence in the bone marrow of a patient with rheumatoid arthritis and progressive multifocal leukoencephalopathy. J Neurovirol. 2008 Oct; 14(5):455-8.
    View in: PubMed
    Score: 0.024
  42. Remission of progressive multifocal leukoencephalopathy and primary central nervous system lymphoma in an HIV-infected patient. Eur J Neurol. 2007 Jun; 14(6):598-602.
    View in: PubMed
    Score: 0.022
  43. A granule cell neuron-associated JC virus variant has a unique deletion in the VP1 gene. J Gen Virol. 2006 Sep; 87(Pt 9):2533-2537.
    View in: PubMed
    Score: 0.020
  44. Progressive multifocal leukoencephalopathy revisited: Has the disease outgrown its name? Ann Neurol. 2006 Aug; 60(2):162-73.
    View in: PubMed
    Score: 0.020
  45. Seizures and their outcome in progressive multifocal leukoencephalopathy. Neurology. 2006 Jan 24; 66(2):262-4.
    View in: PubMed
    Score: 0.020
  46. Elevation of myoinositol is associated with disease containment in progressive multifocal leukoencephalopathy. Neurology. 2004 Sep 14; 63(5):897-900.
    View in: PubMed
    Score: 0.018
  47. Analysis of 15 novel full-length BK virus sequences from three individuals: evidence of a high intra-strain genetic diversity. J Gen Virol. 2004 Sep; 85(Pt 9):2651-2663.
    View in: PubMed
    Score: 0.018
  48. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. Brain. 2004 Sep; 127(Pt 9):1970-8.
    View in: PubMed
    Score: 0.018
  49. New insights into progressive multifocal leukoencephalopathy. Curr Opin Neurol. 2004 Jun; 17(3):365-70.
    View in: PubMed
    Score: 0.018
  50. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 14-2004. A 66-year-old man with progressive neurologic deficits. N Engl J Med. 2004 Apr 29; 350(18):1882-93.
    View in: PubMed
    Score: 0.017
  51. Overview of the cellular immunity against JC virus in progressive multifocal leukoencephalopathy. J Neurovirol. 2002 Dec; 8 Suppl 2:59-65.
    View in: PubMed
    Score: 0.016
  52. Patient Income Does Not Predict Disability or Mortality in Hospitalized COVID-19 Patients in a Large Health Care System in the Chicago Metropolitan Area. J Health Care Poor Underserved. 2022; 33(3):1215-1229.
    View in: PubMed
    Score: 0.015
  53. Advances in Treatment of Progressive Multifocal Leukoencephalopathy. Ann Neurol. 2021 12; 90(6):865-873.
    View in: PubMed
    Score: 0.014
  54. JCV-specific cellular immune response correlates with a favorable clinical outcome in HIV-infected individuals with progressive multifocal leukoencephalopathy. J Neurovirol. 2001 Aug; 7(4):318-22.
    View in: PubMed
    Score: 0.014
  55. JC virus regulatory region tandem repeats in plasma and central nervous system isolates correlate with poor clinical outcome in patients with progressive multifocal leukoencephalopathy. J Virol. 2001 Jun; 75(12):5672-6.
    View in: PubMed
    Score: 0.014
  56. Progressive Multifocal Leukoencephalopathy in a Patient With Progressive Multiple Sclerosis Treated With Ocrelizumab Monotherapy. JAMA Neurol. 2021 06 01; 78(6):736-740.
    View in: PubMed
    Score: 0.014
  57. JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy. J Virol. 2001 Apr; 75(7):3483-7.
    View in: PubMed
    Score: 0.014
  58. Diaphragm and Phrenic Nerve Ultrasound in COVID-19 Patients and Beyond: Imaging Technique, Findings, and Clinical Applications. J Ultrasound Med. 2022 Feb; 41(2):285-299.
    View in: PubMed
    Score: 0.014
  59. Lymphomatoid papulosis and human herpesviruses--A PCR-based evaluation for the presence of human herpesvirus 6, 7 and 8 related herpesviruses. J Cutan Pathol. 2001 Jan; 28(1):29-33.
    View in: PubMed
    Score: 0.014
  60. Transcranial Doppler Ultrasound Evidence of Active Cerebral Embolization in COVID-19. J Stroke Cerebrovasc Dis. 2021 Mar; 30(3):105542.
    View in: PubMed
    Score: 0.014
  61. Clinicopathological characterization of an HIV-2-infected individual with two clonally unrelated primary lymphomas. Am J Hematol. 2000 Dec; 65(4):302-6.
    View in: PubMed
    Score: 0.014
  62. Imaging Review of Peripheral Nerve Injuries in Patients with COVID-19. Radiology. 2021 03; 298(3):E117-E130.
    View in: PubMed
    Score: 0.014
  63. Pharmacovigilance during treatment of multiple sclerosis: early recognition of CNS complications. J Neurol Neurosurg Psychiatry. 2021 02; 92(2):177-188.
    View in: PubMed
    Score: 0.014
  64. Evaluating the impact of antiretroviral and antiseizure medication interactions on treatment effectiveness among outpatient clinic attendees with HIV in Zambia. Epilepsia. 2020 12; 61(12):2705-2711.
    View in: PubMed
    Score: 0.014
  65. Olive Oil Intake Associated with Increased Attention Scores in Women Living with HIV: Findings from the Chicago Women's Interagency HIV Study. Nutrients. 2019 Jul 31; 11(8).
    View in: PubMed
    Score: 0.013
  66. Neurologic illness in Zambia: A neurointensivist's experience. J Neurol Sci. 2018 02 15; 385:140-143.
    View in: PubMed
    Score: 0.011
  67. A Difficult Decision: Atypical JC Polyomavirus Encephalopathy in a Kidney Transplant Recipient. Transplantation. 2017 06; 101(6):1461-1467.
    View in: PubMed
    Score: 0.011
  68. Temporal Patterns and Drug Resistance in CSF Viral Escape Among ART-Experienced HIV-1 Infected Adults. J Acquir Immune Defic Syndr. 2017 06 01; 75(2):246-255.
    View in: PubMed
    Score: 0.011
  69. Phylogenetic associations of human and simian T-cell leukemia/lymphotropic virus type I strains: evidence for interspecies transmission. J Virol. 1994 Apr; 68(4):2693-707.
    View in: PubMed
    Score: 0.009
  70. JC polyomavirus granule cell neuronopathy in a patient treated with rituximab. JAMA Neurol. 2014 Apr; 71(4):487-9.
    View in: PubMed
    Score: 0.009
  71. PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section. Neurology. 2013 Apr 09; 80(15):1430-8.
    View in: PubMed
    Score: 0.008
  72. Clinical Reasoning: An 83-year-old woman with progressive hemiataxia, tremor, and infratentorial lesions. Neurology. 2011 Jul 12; 77(2):e7-10.
    View in: PubMed
    Score: 0.007
  73. [Neurological complication of human immunodeficiency virus infection]. Presse Med. 1991 Jun 22; 20(24):1129-35.
    View in: PubMed
    Score: 0.007
  74. A controlled study of early neurologic abnormalities in men with asymptomatic human immunodeficiency virus infection. N Engl J Med. 1990 Sep 27; 323(13):864-70.
    View in: PubMed
    Score: 0.007
  75. Progressive multifocal leukoencephalopathy in HIV-1 infection. Lancet Infect Dis. 2009 Oct; 9(10):625-36.
    View in: PubMed
    Score: 0.006
  76. Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis. J Neurol Neurosurg Psychiatry. 2006 Sep; 77(9):1079-82.
    View in: PubMed
    Score: 0.005
  77. Polyomavirus nephropathy in kidney transplantation. Prog Transplant. 2004 Jun; 14(2):130-40; quiz 141-2.
    View in: PubMed
    Score: 0.004
  78. The evolving face of human immunodeficiency virus-related progressive multifocal leukoencephalopathy: defining a consensus terminology. J Neurovirol. 2003; 9 Suppl 1:88-92.
    View in: PubMed
    Score: 0.004
  79. Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathy. Neurology. 2001 Oct 09; 57(7):1313-6.
    View in: PubMed
    Score: 0.004
  80. Mesencephalic clefts with associated eye movement disorders. Arch Ophthalmol. 1996 Apr; 114(4):429-32.
    View in: PubMed
    Score: 0.002
  81. Phylogenetic study of ten new HTLV-I strains from the Americas. AIDS Res Hum Retroviruses. 1994 Jan; 10(1):103-6.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.